BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27515188)

  • 1. The ischemic liver cirrhosis theory and its clinical implications.
    Mancuso A
    Med Hypotheses; 2016 Sep; 94():4-6. PubMed ID: 27515188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules.
    Tanaka M; Wanless IR
    Hepatology; 1998 Feb; 27(2):488-96. PubMed ID: 9462648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis development probably arises from chronic micro-vascular ischemia.
    Mancuso A
    Med Hypotheses; 2014 Feb; 82(2):244. PubMed ID: 24389105
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver in haematological disorders.
    Pieri G; Theocharidou E; Burroughs AK
    Best Pract Res Clin Gastroenterol; 2013 Aug; 27(4):513-30. PubMed ID: 24090939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient hepatic attenuation differences (THAD) not connected to focal lesions.
    Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N
    Radiol Med; 2002; 104(1-2):25-43. PubMed ID: 12386553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).
    Wanless IR; Liu JJ; Butany J
    Hepatology; 1995 May; 21(5):1232-7. PubMed ID: 7737628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces.
    Simonetto DA; Yang HY; Yin M; de Assuncao TM; Kwon JH; Hilscher M; Pan S; Yang L; Bi Y; Beyder A; Cao S; Simari RD; Ehman R; Kamath PS; Shah VH
    Hepatology; 2015 Feb; 61(2):648-59. PubMed ID: 25142214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of hepatic vascular diseases.
    Plessier A; Rautou PE; Valla DC
    J Hepatol; 2012; 56 Suppl 1():S25-38. PubMed ID: 22300463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and a Rational Basis of Therapy.
    Gracia-Sancho J; Maeso-Díaz R; Bosch J
    Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosis and cirrhosis reversibility: clinical features and implications.
    Pinzani M; Vizzutti F
    Clin Liver Dis; 2008 Nov; 12(4):901-13, x. PubMed ID: 18984473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin activation and liver inflammation in advanced hepatitis C virus infection.
    González-Reimers E; Quintero-Platt G; Martín-González C; Pérez-Hernández O; Romero-Acevedo L; Santolaria-Fernández F
    World J Gastroenterol; 2016 May; 22(18):4427-37. PubMed ID: 27182154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.
    Wanless IR; Wong F; Blendis LM; Greig P; Heathcote EJ; Levy G
    Hepatology; 1995 May; 21(5):1238-47. PubMed ID: 7737629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.
    Giuli L; Pallozzi M; Venturini G; Gasbarrini A; Ponziani FR; Santopaolo F
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of intrahepatic pressure as an index of hepatic sinusoidal pressure.
    Saito M; Ohnishi K; Terabayashi H; Tanaka H; Iida S; Nomura F
    Am J Gastroenterol; 1987 Oct; 82(10):1057-61. PubMed ID: 3661515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis: a dynamic and potentially reversible process.
    Povero D; Busletta C; Novo E; di Bonzo LV; Cannito S; Paternostro C; Parola M
    Histol Histopathol; 2010 Aug; 25(8):1075-91. PubMed ID: 20552556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct transhepatic assessment of hepatic vein pressure and direction of flow using a thin needle in patients with cirrhosis and Budd-Chiari syndrome. An effective alternative to hepatic vein catheterization.
    Rector WG; Redeker AG
    Gastroenterology; 1984 Jun; 86(6):1395-9. PubMed ID: 6714568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis.
    Jiao LR; Seifalian AM; Habib N; Davidson BR
    Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Portal vein hypertension in chronic liver diseases].
    Mörl M
    Fortschr Med; 1981 Dec; 99(45):1900-4. PubMed ID: 7308958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Budd-Chiari syndrome: a common complication of Behçet's disease.
    Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
    Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular liver diseases].
    Condat B
    Rev Prat; 2015 Jun; 65(6):754-6. PubMed ID: 26298892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.